| Name | Rovadicitinib |
|---|
| Description | Rovadicitinib is a Janus kinase (JAK) inhibitor with an IC50 value <20 nM. Rovadicitinib also exhibits anti-inflammatory activity[1][2]. |
|---|---|
| Related Catalog | |
| References |
[1]. WHO Drug Informat ion - World Health Organization (WHO). |
| Molecular Formula | C17H19N7 |
|---|---|
| Molecular Weight | 321.38 |